Literature DB >> 26141615

Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus.

Jacqueline K Limberg1, Simmi Dube2, Myrthe Kuijpers3, Kathryn E Farni3, Ananda Basu2, Robert A Rizza2, Timothy B Curry3, Rita Basu2, Michael J Joyner3.   

Abstract

PURPOSE: Patients with type 1 diabetes mellitus exhibit impairments in autonomic and cardiovascular control which are worsened with acute hypoglycemia--thus increasing the risk of adverse cardiovascular events. Hypoxia, as seen with the common comorbidity of sleep apnea, may lead to further autonomic dysfunction and an increased risk of ventricular arrhythmias. Therefore, we hypothesized that heart rate variability (HRV) and baroreflex sensitivity (BRS) would be reduced during hypoglycemia in adults with type 1 diabetes, with a further decline when combined with hypoxia.
METHODS: Subjects with type 1 diabetes (n = 13; HbA1c = 7.5 ± 0.3 %, duration of diabetes = 17 ± 5 yrs) completed two 180 min hyperinsulinemic (2 mU/kg TBW/min), hypoglycemic (~3.3 µmol/mL) clamps separated by a minimum of 1 week and randomized to normoxia (SpO2 ~98 %) or hypoxia (SpO2 ~85 %). Heart rate (electrocardiogram) and blood pressure (finger photoplethysmography) were analyzed at baseline and during the hypoglycemic clamp for measures of HRV and spontaneous cardiac BRS (sCBRS).
RESULTS: Hypoglycemia resulted in significant reductions in HRV and sCBRS when compared with baseline levels (main effect of hypoglycemia: p < 0.05). HRV and sCBRS were further impaired during hypoxia (main effect of hypoxia: p < 0.05).
CONCLUSIONS: Acute hypoxia worsens hypoglycemia-mediated impairments in autonomic and cardiovascular control in patients with type 1 diabetes and may increase the risk of cardiovascular mortality. These results highlight the potential cumulative dangers of hypoglycemia and hypoxia in this vulnerable population.

Entities:  

Keywords:  Baroreflex sensitivity; Heart rate variability; Hypoglycemia; Hypoxia; Type 1 diabetes mellitus

Mesh:

Year:  2015        PMID: 26141615      PMCID: PMC4569520          DOI: 10.1007/s10286-015-0301-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  34 in total

Review 1.  The treatment of hypertension in adult patients with diabetes.

Authors:  Carlos Arauz-Pacheco; Marian A Parrott; Philip Raskin
Journal:  Diabetes Care       Date:  2002-01       Impact factor: 19.112

2.  Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients.

Authors:  D J Ewing; J M Neilson; C M Shapiro; J A Stewart; W Reid
Journal:  Br Heart J       Date:  1991-05

3.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

4.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

5.  Heart-rate variability and cardiac autonomic function in diabetes.

Authors:  S C Malpas; T J Maling
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

6.  Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.

Authors: 
Journal:  Am J Med       Date:  1991-04       Impact factor: 4.965

7.  Ventilatory control in diabetes mellitus.

Authors:  J M Montserrat; G M Cochrane; C Wolf; C Picado; J Roca; A Agusti Vidal
Journal:  Eur J Respir Dis       Date:  1985-08

8.  Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise.

Authors:  J G Williams; A I Morris; R C Hayter; C M Ogilvie
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

9.  Peripheral chemoreflex and baroreflex interactions in cardiovascular regulation in humans.

Authors:  John R Halliwill; Barbara J Morgan; Nisha Charkoudian
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

10.  Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy.

Authors:  C Neumann; D Martinez; H Schmid
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

View more
  5 in total

Review 1.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control.

Authors:  Ajay D Rao; Istvan Bonyhay; Joel Dankwa; Maria Baimas-George; Lindsay Kneen; Sarah Ballatori; Roy Freeman; Gail K Adler
Journal:  Diabetes       Date:  2015-10-05       Impact factor: 9.461

3.  Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes.

Authors:  Elaine Chow; Alan Bernjak; Emma Walkinshaw; Alexandra Lubina-Solomon; Jenny Freeman; Ian A Macdonald; Paul J Sheridan; Simon R Heller
Journal:  Diabetes       Date:  2017-01-30       Impact factor: 9.461

4.  Blood Pressure Regulation by the Carotid Sinus Nerve: Clinical Implications for Carotid Body Neuromodulation.

Authors:  Silvia V Conde; Joana F Sacramento; Bernardete F Melo; Rui Fonseca-Pinto; Mario I Romero-Ortega; Maria P Guarino
Journal:  Front Neurosci       Date:  2022-01-10       Impact factor: 4.677

Review 5.  Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis.

Authors:  Rodolfo A Kölliker Frers; Matilde Otero-Losada; Tamara Kobiec; Lucas D Udovin; María Laura Aon Bertolino; María I Herrera; Francisco Capani
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.